Abstract

The mitogen‐activated protein kinases (MAPKs) modulate sympathetic activity within the rostral ventrolateral medulla (RVLM). As intra‐RVLM ethanol causes sympathoexcitation and hypertension in SHRs, we tested the hypotheses: (i) altered MAPKs phosphorylation/dephosphorylation in RVLM underlies ethanol hypertension, and (ii) acetaldehyde, oxidative product of ethanol, replicates molecular and related BP effects of ethanol. The BP effect of either drug was evaluated in presence of inhibitors of JNK (SP600125), ERK1/2 (PD98059), p38 (SB203580), or phosphatase (okadaic acid, OKA). Intra‐RVLM ethanol (10 μg) or acetaldehyde (2 μg) caused similar increases in BP. The pressor action is probably mediated via enhanced ERK1/2 activity because it was (i) paralleled with increased RVLM p‐ERK1/2, and (ii) abolished in PD98059‐treated SHRs. SP600125 abrogated ethanol‐but not acetaldehyde‐evoked hypertension, thus implicating JNK in ethanol effects. Despite increased p‐p38, pharmacological intervention revealed no role for p38 in ethanol hypertension. Although phosphatase activity was not altered by either drug, OKA increased baseline BP and abrogated the pressor effect of ethanol or acetaldehyde. Collectively, enhanced ERK1/2 phosphorylation, without any changes in the dephosphorylation profile, accounts for the pressor effect of ethanol or acetaldehyde in SHRs.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.